A Focus on Life Sciences
Posted by | November 23, 2011
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that we believe will have success with applications they submit to the FDA. In addition, we prefer to put capital to work in device markets where there is more of a commercialization play. We also like selective opportunities in specialty pharmaceutical companies, such as our new partner company Putney.
For more thoughts on the types of life sciences companies we target, watch the Investor Day video below.
(Visited 150 times, 1 visits today)
